{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Oncology Care in Non-small Cell Lung Cancer - Personalizing the Treatment Plan
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Define the classifications of the TNM grouping and staging method as it applies to non-small cell lung cancer.
- Select the medications commonly prescribed to treat non-small cell lung cancer.
- Choose the appropriate interventions for managing patients undergoing treatment for non-small cell lung cancer.
Learning Outcomes
Seventy-five percent of participants will demonstrate competency in clinical reasoning regarding the classification and treatment of non-small cell lung cancer by achieving a minimum score of 70% on the outcomes-based posttest.Disclosures
The author and planners have no relevant financial relationships with any ineligible organizations regarding this activity.
Price:
$24.95
Credits:
- ANCC 2.5 CH
- DC - BON 2.5 CH
- FL - BON 2.5 CH
- GA - BON 2.5 CH
- NM - BON 2.5 CH
- SC - BON 2.5 CH
- WV - BOERN 2.5 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: HHCN0323
Published: Mar/Apr 2023
Expires: 3/6/2026
Sources:
Home Healthcare Now
Required Passing Score: 7/10 (70%)